• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/54

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

54 Cards in this Set

  • Front
  • Back
Km
affinity of enzyme for its substrate
Vmax
proportional to enzyme concentration
decreasing Km will do what to the affinity
decrease affinity
enzyme kinetics graph
1. x intercept
2. y intercept
3. slope
1. 1/-Km
2. 1/Vmax
3. Km/Vmax
EK graph
1. increasing y-intercept, does what to Vmax?
2. further right the x-intercept is, how is Km?
1. decrease Vmax
2. greater the Km
competitive vs. noncompetitive inhibitors on graph
competitive inhibitors cross each other
Vd=
amount of drug in body/plasma drug concentration
low Vd (4-8 L) distribute where?
in blood
medium Vd distribute where
extracellular space or body water
high Vd (greater than body weight) distribute where
in tissues
CL=
rate of elimination of drug/ plama drug concentration
OR
Vd * Ke
t1/2=
0.7 *Vd/ CL
competitive inhibitors
1. resemble substrate
2. overcome by increase in substrate concentration
3. bind active site
4. effect on Vmax
5. effect on Km
1. yes
2. yes
3. yes
4. unchanged
5. increase
noncompetitive inhibitors
1. resemble substrate
2. overcome by increase in substrate concentration
3. bind active site
4. effect on Vmax
5. effect on Km
1. no
2. no
3. no
4. increase
5. unchanged
calculate loading dose
LD= Cp x Vd/F
calculate maintenance dose
MD= Cp x CL/F where Cp= target plasma concentration and F= bioavailability
in patient with impaired renal and hepativ function how is loading dose
remains unchanged although maintenance dose is decreased
zero-order elimination
1. what is it?
2. examples of drugs?
1. -rate of elimination is constant regardless of C (constant AMOUNT of drug eliminated per unit time)
-Cp decrease linearly with time
2. PEA (round)
Phenytoin, Ethanol, Aspirin
First-order elimination
1. what is it?
1. rate of elimination is proportional to drug concentration (constant FRACTION of drug eliminated per unit time)
-Cp decrease exponentially with time
Weak acids
1. Examples
2. trapped where
3. treat overdose with what?
1. phenobarbital, methotrexate, TCas, aspirin
2. in basic environments
3. bicarbonate
Weak bases
1. Examples
2. trapped where
3. treat overdose with what?
1. amphetamines
2. in acidic environments
3. ammonium chloride
Phase I metabolism
-cytochrome P450
-reduction, oxidation, hydrolysis
-usually yields slightly polar, water-soluble metabolites
Phase II metabolism
-conjugation
-acetylayion, glucuronidation, sulfation
-usually yields very polar, inactive metabolites
-renally excreted
Efficacy
maximal effect a drug can produce
potency
amount of drug needed for a given effect
competitive anatagonist shifts curve how? does what?
to the right
-decreasing potency
-increasing EC50
noncompetitve anatagonist shifts curve how? does what?
downward
-decreasing efficacy
partial agonist acts where?
does what?
how is potency?
-acts on smae receptor system as full agonist
-lower maximal efficacy regardless of dose
-is an independent factor
therapeutic index is measurement of what?
drug safety
TI=
LD50/ED50 or median toxic dose/ median effective dose
TILE (TI= L/E)
TI of safer drugs
safer drugs have higher TI values
Phase I biotransformation classification
-modification of drug molecule via oxidation, reduction, or hydrolysis******
-CYP450
-require for molecular oxygen and NADPH
CYP450 IA2
1. substrate example
2. inducers
3. inhibitors
4. genetic polymorphism
1. theophylline, acetaminophen
2. aromatic hydrocarbons (smoke), cruciferous veggies
3. quinolones, macrolides
4. no
smoker w/ theophylline
-if quit smoking, need to lower dose b/c toxicity
-in current smoker, plasma levels lower so need to increase dose
CYP 450 2C9
1. substrate example
2. inducers
3. inhibitors
4. genetic polymorphism
1. phenytoin, warfarin
2. general inducers
3.--
4. yes
CYP 450 2D6
1. substrate example
2. inducers
3. inhibitors
4. genetic polymorphism
1. many cardio and CNS drugs
2. none known
3. haloperidol, quinidine
4. yes
CYP 450 3A4
1. substrate example
2. inducers
3. inhibitors
4. genetic polymorphism
1. 60% of drugs in PDR
2. general inducers
3. general inhibitors, grapefruit juice
4. no
grape fruit juice
-high cholesterol and on statin and drink GF juice-- increase risk of statin toxicity
-active component- furanocoumarins
-Ex. alprazolam, midazolam, atorvastin*****, and cyclosporine
cimetidine
-for ulcers
-inhibit metabolism of drug and plasma level increase
general inducers
Smoking PCP on a RAG
-smoking
-PCP
-rifampin
-anticonvulsants (barbs, phenytoin, carbamazepine)
-glucocorticoids,
-alcohol
---stimulate liver to make more enzymes
-lowers plasma level of substrate and makes less effective
general inhibitors
-Grapefuit juice and COKE with your PIe
-pi= protease inhibitor- ritovir
-cimetidine, omeprazole, ketoconazole
-chloramphenical
-macrolides
-acute alcohol
-raises plasma level of substrate and make more effective
pt. given on theophylline and has chronic broncitis is given macrolides
-want to bronchodilate
-macrolides- for resp. infection
-increase plasma level of theophylline
-increase risk of toxicity
what is elimination
termination of drug action
2 major ways to get rid of drugs
biotransformation
-excretion
zero-order elimination rate
-constant AMOUNT of drug is eliminated per unit of time
-no half-life
-rate of elimination is indepent of plasma concentration
= high dose (saturation, working at max capacity)
3 drugs with zero-order elimination
1. ethanol
2. phentoin
3. aspirin
-at high doese
zero-order graphs
1. x- time and y-units of drug
2. x- time and y-log units of drug
1. down linear
2. upside-down- U but decreasing
first-order elimination
-constant fraction of drug is eliminated per unit time
-half-life applies
Phase II biotransformation
-conjugation with endogenous compounds via activity of TRANSFERASES
-conjugation--glucoronidation, acetylation, glutathione conjugation
Glucoronosyl transferase*****
-involved in glucoronidation
acetylation
phase II
-drug induced SLE by slow acetylators-- (hydralazine*****> procainamine> isoniazid
"It's HIP to have lupus"
-CV: chloramphenicol toxicity
-Grey-Baby syndrome
-mech of toxicity- b/c neonates have lower lvels of GT and can't metabolize
CV: GT deficiency
Gilbert or Crigler-Najjar
-can't conjugate bilirubin
-get jaundice
CV: butterfly malar rash; +ANA
-antihistones antibodies= drug-induced
-stop drug and SLE goes away